KOMPAS.com – A recent research results show, drugs diabetes can play a role in lowering body weight obese people.
“Medical care brings 10 percent weight loss in the majority respondents, and even 20 percent weight loss in more than a third of respondents. “
“This is the beginning of a new era,” said one of the researchers involved in the study, and professor of endocrinology, Rachel Batterham.
Also read: Yoga Tips for Weight Loss
A total of 1,961 adults from North America, South America, Asia and Europe took part in the 68-week trial throughout 2018.
In it used semaglutide drugs or anti-diabetes drugs commonly used for the treatment of type 2 diabetes.
These people received semaglutide injections under the skin and some received a placebo every week.
In addition, respondents also attended counseling sessions for a low calorie diet and increased exercise.
Semaglutide is sold under the names Ozempic and Rybelsus by the Danish drug company Novo Nordisk.
“Participants who received semaglutide lost 5-20 percent or more of their body weight at week 68, compared with those receiving placebo,” the study said.
Also read: Children Can Have Diabetes, This Is What Parents Need To Know
Participants aged 18 years and over, with one or more previous diet attempts to lose weight tend to have a normal body mass index (BMI) of 18.5-24.9.
The researchers said treatment with semaglutide once a week plus healthy lifestyle interventions led to sustained weight loss in obese (non-diabetic) adults.
Clinically the treatment was highly relevant at 14.9 percent, with 86 percent of participants achieving at least a five percent weight loss.
Novo Nordisk shipped semaglutide as a weight management treatment for regulatory approval to Food and Drug Administration, United States, and European Medicines Agency.
– .